MMedication Read More 11 Things People Keep Getting Wrong About GLP-1s29 April 2026 There’s no question that GLP-1 receptor agonist drugs like Wegovy and Ozempic have shifted how we think about…
MMedication Read More DOCTORSPEAK: ‘Slimming shot’ that can save heart, kidneys & brain1 April 2026 ONE of my patients, Rajesh (52), a businessman, is a long-time diabetes patient. Despite being on multiple medications,…
MMedication Read More 13 surprising ways GLP-1 weight-loss drugs may benefit the body, according to science31 March 2026 A condition-by-condition guide to GLP-1 drugs breaks down what’s proven, what’s promising and what’s still untested. Humans have…
MMedication Read More Stopping GLP-1 drugs like Ozempic can raise risk of heart attack & death, warns new study | The study published in BMJ Medicine | Inshorts – Inshorts21 March 2026 Stopping GLP-1 drugs like Ozempic can raise risk of heart attack & death, warns new study | The…
MMedication Read More Colorado bill targets compounded weight loss drugs5 March 2026 A bipartisan bill at the state capitol in Denver is targeting compounded versions of popular weight loss drugs…
MMedication Read More Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead15 January 2026 Published: Jan. 15, 2026 at 11:51 a.m. ET Millions of Americans have tried GLP-1s, but some people find that…
FFitness Read More Fitness coach warns that GLP-1 weight loss drugs aren’t for everyone, explains who they are really meant for9 October 2025 Weight loss is rarely a straight path – it can be a long, challenging journey filled with ups…
MMedication Read More Wegovy pill could deliver as much weight loss as the shot, trial shows20 September 2025 Eli Lilly and Novo Nordisk are vying for supremacy in the weight-loss market they dominate as they both…
MMedication Read More Researchers work to make GLP-1 medications available in pill form29 May 2025 WEST MICHIGAN — Used as treatments for type 2 diabetes, blood sugar control and weight loss, researchers are…
GGenetics Read More GLP1 agonists linked to depression risk in new genetic study18 April 2025 A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely…